Foscarnet

CHEMBL666 Phase 4 Approuvé Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
126.0 g/mol
LogP
-2.0
Phase
4

This antiviral medication works by directly blocking the active site of viral DNA polymerase without requiring activation by viral enzymes, making it effective against viruses resistant to other antivirals. It is used to treat serious cytomegalovirus and herpes infections in immunocompromised patients.

Masse moléculaire

126,0100 g/mol

LogP

-2,00

TPSA

94,80 Ų

Règle des 5 de Lipinski

Conforme

Aires thérapeutiques

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Structure 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

O=C(O)P(=O)(O)O

InChI

InChI=1S/CH3O5P/c2-1(3)7(4,5)6/h(H,2,3)(H2,4,5,6)

Molecular Formula

CH3O5P

HBD / HBA

3 / 5

Liaisons Rotatives

1

Atomes Lourds

7

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

This antiviral medication works by directly blocking the active site of viral DNA polymerase without requiring activation by viral enzymes, making it effective against viruses resistant to other antivirals. It is used to treat serious cytomegalovirus and herpes infections in immunocompromised patients.

Yes, Foscarnet is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL666. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 3415. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.